In Hee Kim
Overview
Explore the profile of In Hee Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1366
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim A, Shin D, Seo Y, Kang D, Min Y, Kim I, et al.
Adv Ther
. 2025 Feb;
42(3):1570-1581.
PMID: 39932678
Introduction: Tegoprazan is a potassium-competitive acid blocker, and its systemic exposure is presumably affected by hepatic clearance and bioavailability. This study aimed to investigate the effect of hepatic impairment (HI)...
2.
Kim J, Kim S, Song D, Kim H, Yoon E, Park J, et al.
Ann Med
. 2025 Jan;
57(1):2428431.
PMID: 39856091
Background/aims: Acute decompensation (AD) is defined as the development of complications related to portal hypertension and liver dysfunction that affect the progression of chronic liver disease (CLD) or liver cirrhosis...
3.
Lee J, Kim I, Seol D, Lee S, Yoo M, Lee T, et al.
Ann Surg Oncol
. 2025 Jan;
PMID: 39847282
Background: Three dimensional (3D) cell cultures can be effectively used for drug discovery and development but there are still challenges in their general application to high-throughput screening. In this study,...
4.
Yim H, Seo Y, Kim J, Kim W, Jung Y, Jang J, et al.
Clin Mol Hepatol
. 2025 Jan;
PMID: 39828249
Background/aims: Besifovir (BSV) showed comparable antiviral activity superior safety profiles to tenofovir disoproxil fumarate (TDF) in treatment-naïve chronic hepatitis B (CHB). However, no data are available regarding the antiviral efficacy...
5.
Lee C, You G, Jo H, Jun C, Cho E, Kim I, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766066
Radiofrequency ablation (RFA) is an important local treatment for hepatocellular carcinoma (HCC). This study aimed to evaluate the characteristics of tumor recurrence after RFA and analyze predictors of tumor recurrence...
6.
Jeong C, Choi G, Jang E, Kim Y, Lee Y, Kim I, et al.
Sci Rep
. 2024 Nov;
14(1):28622.
PMID: 39562603
No abstract available.
7.
8.
Lee C, Kim I, Jeong S
Clin Mol Hepatol
. 2024 Jul;
30(4):997-999.
PMID: 39069723
No abstract available.
9.
Sohn W, Park S, Lee T, Chon Y, Kim I, Lee B, et al.
EClinicalMedicine
. 2024 Jun;
73:102671.
PMID: 38881570
Background: It is unclear whether direct-acting antivirals (DAAs) treatment improves the disease burden in hepatitis C virus (HCV) infection. This study aimed to investigate the effect of DAA treatment on...
10.